In details, the animal studies revealed that the activation of JNK-1 by WNT5A impairs the activity of a target protein called insulin receptor substrate-1 (IRS-1) leading to suppressed insulin signaling and development of insulin resistance [30]. The gene discussed is MAPK8; the disease is Insulin resistance.